Carlo Ganini

1.6k total citations
30 papers, 740 citations indexed

About

Carlo Ganini is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Carlo Ganini has authored 30 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Carlo Ganini's work include Renal cell carcinoma treatment (8 papers), Renal and related cancers (6 papers) and Cancer-related Molecular Pathways (4 papers). Carlo Ganini is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Renal and related cancers (6 papers) and Cancer-related Molecular Pathways (4 papers). Carlo Ganini collaborates with scholars based in Italy, Canada and United States. Carlo Ganini's co-authors include Camillo Porta, Ilaria Imarisio, Chiara Paglino, Silvia Dragoni, Franco Tanzi, Vittorio Rosti, Gerry Melino, Francesco Moccia, Paolo Pedrazzoli and Eleonora Candi and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Carlo Ganini

27 papers receiving 734 citations

Peers

Carlo Ganini

ONCOL

PRM

GENET

Xiaoxi Chen China

Hiroki Shimizu Japan

Yoshitaka Konda Japan

James V. Michael United States

Masahiro Shiba Japan

María‐José Barrera Chile

Ömer Faruk Hatipoğlu Japan

Yan Pan China

Kai‐Hu Shi China

Qilin Ao China

Xiaoxi Chen China

Carlo Ganini

269 ×0.8

184 ×1.1

ONCOL

225 ×1.4

PRM

221 ×1.7

26 ×0.2

GENET

Citations per year, relative to Carlo Ganini Carlo Ganini (= 1×) peers Xiaoxi Chen

Countries citing papers authored by Carlo Ganini

Since Specialization

Citations

This map shows the geographic impact of Carlo Ganini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Ganini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Ganini more than expected).

Fields of papers citing papers by Carlo Ganini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Ganini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Ganini. The network helps show where Carlo Ganini may publish in the future.

Co-authorship network of co-authors of Carlo Ganini

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Ganini. A scholar is included among the top collaborators of Carlo Ganini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Ganini. Carlo Ganini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marrano, Nicola, Carlo Ganini, Angelo Cignarelli, et al.. (2025). Risk factors for endocrinological immune-related adverse events in patients with renal cell carcinoma treated with immune checkpoint inhibitors. Journal of Endocrinological Investigation. 49(2). 399–412.

Scotti, Claudia, Ornella Cazzalini, M. Andrea Previtali, et al.. (2024). Differential effect of asparagine and glutamine removal on three adenocarcinoma cell lines. Heliyon. 10(15). e35789–e35789. 1 indexed citations

Pirovano, Marta, Carlo Ganini, Maurizio Gallieni, Camillo Porta, & Laura Cosmai. (2024). Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrology. Journal of Nephrology. 38(5). 1369–1379.

Smirnov, Artem, Carlo Ganini, Xue Yang, et al.. (2023). p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancer. Biology Direct. 18(1). 73–73. 7 indexed citations

Montanaro, Manuela, Massimiliano Agostini, Lucia Anemona, et al.. (2023). ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer. International Journal of Molecular Sciences. 24(7). 6519–6519. 3 indexed citations

Rizzo, Mimma, Anna Caliò, Matteo Brunelli, et al.. (2023). Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification. Cancer Treatment Reviews. 116. 102558–102558. 23 indexed citations

Novelli, Flavia, Carlo Ganini, Gerry Melino, et al.. (2022). p63 in corneal and epidermal differentiation. Biochemical and Biophysical Research Communications. 610. 15–22. 18 indexed citations

Bertolo, Riccardo, Chiara Cipriani, Matteo Vittori, et al.. (2022). The efficacy of a suppository based on Phenolmicin P3 and Bosexil (Mictalase®) in control of irritative symptoms in patients undergoing thulium laser enucleation of prostate: a single-center, randomized, controlled, open label, phase III study. BMC Urology. 22(1). 19–19. 1 indexed citations

Ganini, Carlo, Ivano Amelio, Riccardo Bertolo, et al.. (2021). Serine and one-carbon metabolisms bring new therapeutic venues in prostate cancer. Discover Oncology. 12(1). 45–45. 8 indexed citations

10.

Rozenberg, Julian M., Svetlana Zvereva, Ilya Zubarev, et al.. (2021). The p53 family member p73 in the regulation of cell stress response. Biology Direct. 16(1). 23–23. 49 indexed citations

11.

Petagna, Lorenzo, Amedeo Antonelli, Carlo Ganini, et al.. (2020). Pathophysiology of Crohn’s disease inflammation and recurrence. Biology Direct. 15(1). 23–23. 160 indexed citations

12.

Ganini, Carlo, et al.. (2020). The biochemistry of cell death. Cell Death and Disease. 11(4). 2 indexed citations

13.

Agostini, Massimiliano, Carlo Ganini, Eleonora Candi, & Gerry Melino. (2020). The role of noncoding RNAs in epithelial cancer. Cell Death Discovery. 6(1). 13–13. 36 indexed citations

14.

Porta, Camillo, et al.. (2015). Tivantinib (ARQ197) in hepatocellular carcinoma. Expert Review of Anticancer Therapy. 15(6). 615–622. 13 indexed citations

15.

Dragoni, Silvia, Ilaria Turin, Umberto Laforenza, et al.. (2014). Store-Operated Ca²⁺Entry Does Not Control Proliferation in Primary Cultures of Human Metastatic Renal Cellular Carcinoma. BioMed Research International. 2014. 1–19. 55 indexed citations

16.

Moccia, Francesco, Silvia Dragoni, Valentina Poletto, et al.. (2014). Orai1 and Transient Receptor Potential Channels as Novel Molecular Targets to Impair Tumor Neovascularization in Renal Cell Carcinoma and other Malignancies. Anti-Cancer Agents in Medicinal Chemistry. 14(2). 296–312. 46 indexed citations

17.

Porta, Camillo, Chiara Paglino, Ilaria Imarisio, et al.. (2012). Changes in Circulating Pro-Angiogenic Cytokines, other than VEGF, before Progression to Sunitinib Therapy in Advanced Renal Cell Carcinoma Patients. Oncology. 84(2). 115–122. 69 indexed citations

18.

Ganini, Carlo, Angioletta Lasagna, Chiara Paglino, et al.. (2012). Lingual Metastasis from Renal Cell Carcinoma: A Case Report and Literature Review. Rare Tumors. 4(3). 130–133. 14 indexed citations

19.

Lodola, Francesco, Umberto Laforenza, Elisa Bonetti, et al.. (2012). Store-Operated Ca2+ Entry Is Remodelled and Controls In Vitro Angiogenesis in Endothelial Progenitor Cells Isolated from Tumoral Patients. PLoS ONE. 7(9). e42541–e42541. 143 indexed citations

20.

Porta, Camillo, Chiara Paglino, Ilaria Imarisio, Carlo Ganini, & Paolo Pedrazzoli. (2011). Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?. Journal of Cancer. 2. 333–338. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact